1460883280-2db6ca0c-aa24-4e57-8467-6d796dffaaf8

1. A process for isolating substantially pure L-\u03b2-3-indolylalanine (L-\u03b2-3) from a source of amino acids including L-\u03b2-3, the process comprising:
contacting a porous container containing a hydrophobic substance being attractive to aromatic amino acids and having substantially no attraction to aliphatic amino acids with an aqueous solution of the source of amino acids;
agitating the aqueous solution and the porous container to allow a substantial portion of the L-\u03b2-3 to adsorb to the hydrophobic substance and thereby produce a first solution containing aliphatic amino acids;
separating the porous container from the aqueous solution;
contacting the porous container with an acidic solution to produce a second solution containing any L-phenylalanine and L-tyrosine displaced from the hydrophobic substance, wherein the acidic solution includes an acid selected from one or more of a group consisting of acetic acid, formic acid, propionic acid, butyric acid, isobutyric acid, and acids having a molecular weight no greater than 88.10 daltons and a Ka in the range of 1.77\xd710\u22124 and 1.34\xd710\u22125 at 25\xb0 C.;
separating the porous container from the second solution; and
contacting the porous container with a basic solution to displace L-\u03b2-3 from the hydrophobic substance and thereby produce a third solution containing L-\u03b2-3 , wherein the basic solution includes a base selected from one or more of a group consisting of ammonia, short chain aliphatic primary, secondary or tertiary amines, trimethylamine, triethylamine, (CH3)2NH (C2H5NH, CH3NH2, CH2CH2NH2and bases having a molecular weight no greater than 101.19 daltons and a Kbin the range of 1.26\xd710\u22123 and 1.8\xd710\u22125 at 25\xb0 C.
2. The process of claim 1, further comprising the step of recovering L-\u03b2-3 from the third solution.
3. Substantially pure L-\u03b2-3 made by the process of claim 2.
4. The process of claim 2, wherein the step of recovering is performed by a process selected from one or more of a group consisting of separation by filtration, separation by centrifugation, separation by evaporation and separation by crystallization.
5. The process of claim 1, wherein the source of amino acids is selected from one or more of a group consisting of a protein hydrolysate of natural proteins, an enzymatic hydrolysate of casein and an enzymatic hydrolysate of soy protein.
6. The process of claim 1, wherein the hydrophobic substance includes a polymeric resin.
7. The process of claim 6, wherein the resin is selected from one or more of a group consisting of a porous resin, a non-ionic resin, a non-ionic porous resin, a non-ionic cross-linked polystyrene, a particulate-form resin, and a bead-form resin.
8. The process of claim 1, wherein the basic solution includes a base selected from one or more of a group consisting of ammonia, short chain aliphatic primary, secondary or tertiary amines, trimethylamine, triethylamine, (CH3)2NH, (C2 H5)2NH, CH3NH2, CH2CH2NH2and bases having a molecular weight no greater than 101.19 daltons and a Kb in the range of 1.26\xd710\u22123 and 1.8\xd710\u22125 at 25\xb0 C.
9. The process of claim 1, further comprising combining at least a portion of the first solution with at least a portion of the third solution.
10. A mixture of amino acids produced by the process of claim 9.
11. The process of claim 1, further comprising recovering the aliphatic amino acids from the first solution.
12. The process of claim 1, further comprising recovering the L-phenylalanine and L-tyrosine from the second solution.
13. The process of claim 1, further comprising washing the porous container with a wash solution containing water prior to at least one of the contacting steps.
14. The process of claim 13, further comprising washing the porous container with a wash solution containing water prior to all of the contacting steps.
15. The process of claim 13, wherein the wash solution further includes an alcohol.
16. The process of claim 1, wherein the porous container is adapted to retain the hydrophobic substance in a packed configuration.
17. The process of claim 1, wherein the porous container is adapted to retain the hydrophobic substance therein while enabling the hydrophobic substance to move freely within the container.
18. A process for obtaining amino acids from a mixture of amino acids, the process comprising:
providing an aqueous solution of a mixture of amino acids that includes L-\u03b2-3-indolylalanine (L-\u03b2-3);
contacting the aqueous solution with a hydrophobic substance to form a first solution comprising non-aromatic amino acids, wherein the hydrophobic substance is attractive to aromatic amino acids and has substantially no attraction to aliphatic amino acids;
eluding the hydrophobic substance with an acid to provide a second solution comprising monocyclic amino acids;
eluding the hydrophobic substance with a base to provide a third solution comprising L-\u03b2-3, and
recovering at least one of a group selected from the non-aromatic amino acids from the first solution, the monocyclic amino acids from the second solution, and the L-\u03b2-3 from the third solution.
19. The process of claim 18, wherein the mixture of amino acids is obtained from one or more of a group consisting of a protein hydrolysate of natural proteins, an enzymatic hydrolysate of casein and an enzymatic hydrolysate of soy protein.
20. The process of claim 18, wherein the hydrophobic substance includes a resin selected from one or more of a group consisting of a porous resin, a non-ionic resin, a non-ionic porous resin, a non-ionic cross-linked polystyrene, a particulate-form resin, and a bead-form resin.
21. The process of claim 18, wherein the acid is selected from one or more of a group consisting of acetic acid, formic acid, propionic acid, butyric acid, isobutyric acid, and acids having a molecular weight no greater than 88.10 daltons and a Ka in the range of 1.77\xd710\u22124 and 1.34\xd710\u22125 at 25\xb0 C.
22. The process of claim 18, wherein the base is selected from one or more of a group consisting of ammonia, short chain aliphatic primary, secondary or tertiary amines, trimethylamine, triethylamine, (CH3)2NH, (C2H5)2NH, CH3NH2, CH2CH2NH2and bases having a molecular weight no greater than 101.19 daltons and a Kb in the range of 1.26\xd710\u22123and 1.8\xd710\u22125at 250\xb0 C.
23. The process of claim 18, wherein the step of recovering is performed by a process selected from one or more of a group consisting of separation by filtration, separation by centrifugation, separation by evaporation and separation by crystallization.
24. The process of claim 18 further comprising the step of combining at least a portion of the first solution with at least a portion of the third solution.
25. The process of claim 18, wherein the recovering step includes recovering the non-aromatic amino acids from the first solution.
26. The process of claim 18, wherein the recovering step includes recovering the monocyclic amino acids from the second solution.
27. The process of claim 18, wherein the recovering step includes recovering the L-\u03b2-3 from the third solution.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A medical device configured for passage through a biological lumen of a patient, comprising:
a plurality of strut members, comprising:
discrete elongated inner strut members; and
discrete elongated outer strut members interlinked to the plurality of elongated inner strut members by a plurality of swivel joints to form a shaped structure comprising a compressed orientation and an expanded orientation;

wherein each inner strut member is interlinked with at least three outer strut members and none of the inner strut members are interlinked to another inner strut member; and
wherein each outer strut member is interlinked with at least three inner strut members and none of the outer strut members is interlinked to another outer strut member, and wherein at each swivel joint, the inner strut members are located closer to a central axis of the apparatus than the outer strut members.
2. The apparatus of claim 1, further comprising an actuation mechanism to urge the swivel joints within a range of motion.
3. The apparatus of claim 1, wherein a swivel joint forms a scissor mechanism with an inner strut member and an outer strut member.
4. The apparatus of claim 3, wherein the inner strut members and the outer strut members are arranged as a series of linked scissor mechanisms.
5. The apparatus of claim 1, further comprising a prosthetic valve coupled to the shaped structure.
6. The apparatus of claim 5, wherein the prosthetic valve comprises:
a first structural member coupled to the plurality of strut members;
a second structural member rotatable relative to the first structural member; and
a plurality of pliable valve members connecting the first structural member with the second structural member such that rotation of the second structural member relative to the first structural member urges the valve members between an open and a closed state.
7. The apparatus of claim 6, wherein the rotation of the second structural member is responsive to the natural flow of a biological fluid.
8. The apparatus of claim 5, wherein the prosthetic valve includes a plurality of pliable valve leaflets having commissures at the intersection of two strut members.
9. The apparatus of claim 8, wherein the prosthetic valve includes a skirt material coupled to the strut members.
10. The apparatus of claim 1, wherein the shaped structure is one of a cylindrical, a conical, or an hourglass shape.
11. A medical stent, comprising:
a plurality of elongated strut members, including inner strut members and outer strut members; and
articulations connecting the inner strut members and the outer strut members such that:
each inner strut member comprises articulations with three outer strut members;
none of the inner strut members comprises articulations with another inner strut member;
each outer strut member comprises articulations with three inner strut members; and
none of the outer strut members comprises articulations with another outer strut member, and wherein at each articulation, when the stent is at a maximally expanded orientation, the inner strut members are located closer to a central axis of the stent than the outer strut members.
12. The stent of claim 11, wherein the articulation form scissor mechanisms with the inner strut members and the outer strut members.
13. The stent of claim 12, wherein at least one articulation bisects an inner strut member and an outer strut member.
14. The stent of claim 12, wherein the plurality of strut members are arranged as a series of linked scissor mechanisms.
15. The stent of claim 11, wherein at least one articulation interconnects a first end of an inner strut member with a first end of an outer strut member.
16. The stent of claim 11, further comprising an adjustment mechanism to exerting a force to urge the plurality of strut members about the articulations within a range of motion.
17. The stent of claim 11, wherein the inner and outer strut members are non-linear.
18. The stent of claim 11, further comprising a prosthetic valve coupled to the plurality of strut members.
19. The stent of claim 18, wherein the prosthetic valve comprises:
a first structural member coupled to the plurality of strut members;
a second structural member rotatable relative to the first structural member; and
a plurality of pliable valve members connecting the first structural member with the second structural member such that rotation of the second structural member relative to the first structural member urges the valve members between an open and a closed state.
20. The stent of claim 19, wherein the rotation of the second structural member is responsive to the natural flow of a biological fluid.
21. The stent of claim 18, wherein the prosthetic valve includes a plurality of pliable valve leaflets having commissures at the intersection of two strut members.
22. The stent of claim 21, wherein the prosthetic valve includes a skirt material coupled to the plurality of strut members.
23. The stent of claim 11, wherein the plurality of strut members are arranged to form one of a cylindrical, a conical, or an hourglass shape.
24. The stent of claim 16, wherein the adjustment mechanism is a screw mechanism.
25. The stent of claim 24, wherein the screw mechanism is permanently attached to the plurality of strut members.
26. The stent of claim 11, wherein the stent is coupled to a catheter.